Bundesinstitut Fur Impfstoffe und Biomedizinische Arzneimittel

Where the EU money came from

Funding by EU programme. Amounts are Bundesinstitut Fur Impfstoffe und Biomedizinische Arzneimittel's own share of each project, not the project's full budget.

Projects

34 EU-funded projects, newest first. Each links to the official record.

• VIBESAssociated partner

  Integrating virology, artificial intelligence and biophotonics for innovative antiviral strategies against emerging flaviviruses

  Horizon Europe · 2027–2030 · Project on CORDIS ↗
• REGolutionPartner

  A training program on novel quantitative methods in regulatory decision making

  Horizon Europe · 2027–2030 · Project on CORDIS ↗

  €581ktheir share
• iN-KEYPartner

  iNK Cell–Driven Strategies for Enhanced Multiple Myeloma ImmunotherapY

  Horizon Europe · 2026–2031 · Project on CORDIS ↗

  €804ktheir share
• EURL-IVD.3Partner

  Harmonization process of European Reference Laboratories for in vitro diagnostics 2026

  EU4Health Programme (EU4H) · 2026–2027 · Project on the EU portal ↗

  €1.1Mtheir share
• JA STOCKPILEPartner

  Joint action on comprehensive and sustainable strategic stockpiles of medical countermeasures used in crisis

  EU4Health Programme (EU4H) · 2025–2028 · Project on the EU portal ↗

  €493ktheir share
• EVHPartner

  European Vaccines Hub for Pandemic Readiness

  EU4Health Programme (EU4H) · 2025–2029 · Project on the EU portal ↗

  €15.8Mtheir share
• VIROMARKERSPartner

  Virus related biomarkers to improve management of chronic conditions

  Horizon Europe · 2025–2028 · Project on CORDIS ↗

  €86ktheir share
• ERDERAPartner

  EUROPEAN RARE DISEASES RESEARCH ALLIANCE

  Horizon Europe · 2024–2031 · Project on CORDIS ↗

  €129ktheir share
• EURL-IVD.1Partner

  Harmonization process of European Reference Laboratories for in vitro diagnosis

  EU4Health Programme (EU4H) · 2024–2025 · Project on the EU portal ↗

  €235ktheir share
• IncreaseNETAssociated partner

  Supporting the increased capacity and competence building of the EU medicines regulatory network

  EU4Health Programme (EU4H) · 2024–2027 · Project on the EU portal ↗

  €478ktheir share
• ECOWAS-RegECsPartner

  Practical strengthening of regulatory and ethics oversight on clinical trials in West Africa using Lassa Fever vaccine development projects and increase regulatory maturity level in targeted countries

  Horizon Europe · 2023–2025 · Project on CORDIS ↗
• CHESSMENAssociated partner

  Coordination and Harmonization of the Existing Systems against Shortage of Medicine - European Network

  EU4Health Programme (EU4H) · 2023–2027 · Project on the EU portal ↗

  €170ktheir share
• ALLPreTPartner

  Allergenicity Prediction Toolbox for novel foods

  Horizon Europe · 2022–2027 · Project on CORDIS ↗

  €261ktheir share
• Inno4VacPartner

  Innovations to accelerate vaccine development and manufacture

  Horizon 2020 · 2021–2028 · Project on CORDIS ↗

  €437ktheir share
• T-OPPartner

  Training Network for Optimizing Adoptive T cell Therapy of Cancer

  Horizon 2020 · 2021–2025 · Project on CORDIS ↗

  €253ktheir share
• EuroGCTPartner

  European consortium for communicating gene- and cell-based therapy information.

  Horizon 2020 · 2021–2026 · Project on CORDIS ↗
• T2EVOLVEPartner

  Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy

  Horizon 2020 · 2021–2025 · Project on CORDIS ↗

  €479ktheir share
• TIPATPartner

  Training towards Personalized Antibiotic Treatment

  Horizon 2020 · 2020–2024 · Project on CORDIS ↗

  €506ktheir share
• imSAVARPartner

  Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

  Horizon 2020 · 2019–2025 · Project on CORDIS ↗

  €603ktheir share
• EU-PEARLPartner

  EU Patient- cEntric clinicAl tRial pLatform

  Horizon 2020 · 2019–2023 · Project on CORDIS ↗

  €318ktheir share
• COMBINEPartner

  Collaboration for Prevention and Treatment of MDR Bacterial Infections

  Horizon 2020 · 2019–2027 · Project on CORDIS ↗

  €1.5Mtheir share
• STACCATOPartner

  European Industrial Doctorate for enhancing upstream biopharmaceutical manufacturing process development through single cell analysis

  Horizon 2020 · 2019–2022 · Project on CORDIS ↗

  €506ktheir share
• STARSPartner

  Strengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS)

  Horizon 2020 · 2019–2022 · Project on CORDIS ↗

  €190ktheir share
• GAPPPartner

  facilitatinG the Authorisation of Preparation Process for blood and tissues and cells

  3rd Health Programme · 2018–2022 · Project on the EU portal ↗

  €230ktheir share
• CARAMBAPartner

  SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease

  Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  €343ktheir share
• CCHFVaccinePartner

  Crimean-Congo Haemorrhagic Fever Vaccine

  Horizon 2020 · 2017–2025 · Project on CORDIS ↗

  €136ktheir share
• VAC2VACPartner

  Vaccine lot to Vaccine lot comparison by consistency testing.

  Horizon 2020 · 2016–2022 · Project on CORDIS ↗

  €1.0Mtheir share
• CARATPartner

  Chimeric Antigen Receptors (CARs) for Advanced Therapies

  Horizon 2020 · 2016–2019 · Project on CORDIS ↗

  €716ktheir share
• FLUCOPPartner

  Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection

  FP7 (2007 to 2013) · 2015–2020 · Project on CORDIS ↗

  €632ktheir share
• TBVAC2020Partner

  TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development

  Horizon 2020 · 2015–2019 · Project on CORDIS ↗
• IFAAMPartner

  Integrated Approaches to Food Allergen and Allergy Risk Management

  FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

  €303ktheir share
• TARGETAMDPartner

  Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD)

  FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

  €301ktheir share
• ABIRISKPartner

  Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk

  FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

  €634ktheir share
• PERSISTPartner

  Persisting Transgenesis

  FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

  €458ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Institut National de la Sante et de la Recherche MedicaleFrance · 8 shared projects
• Academisch Ziekenhuis LeidenNetherlands · 8 shared projects
• University College LondonUnited Kingdom · 7 shared projects
• Istituto Superiore di SanitaItaly · 6 shared projects
• Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 5 shared projects
• Karolinska InstitutetSweden · 5 shared projects
• Universita Degli Studi di SienaItaly · 5 shared projects
• Ages - Osterreichische Agentur Fur Gesundheit und Ernahrungssicherheit GmbHAustria · 5 shared projects
• Nemzeti Nepegeszsegugyi Es Gyogyszereszeti KozpontHungary · 5 shared projects
• Miltenyi Biotec BV & Co KGGermany · 5 shared projects
• LakemedelsverketSweden · 5 shared projects
• Laakealan Turvallisuus-Ja KehittamiskeskusFinland · 5 shared projects
• Centre National de la Recherche Scientifique CNRSFrance · 4 shared projects
• The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 4 shared projects
• Danmarks Tekniske UniversitetDenmark · 4 shared projects
• Imperial College of Science Technology and MedicineUnited Kingdom · 4 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• DNA
• HIV
• bacteriology
• big data
• cells technologies
• clinical medicine
• crisis management
• databases
• domestic animals
• eHealth
• ecosystems
• emission spectroscopy
• employment
• entomology